IP2IPO is a recent float, at the back end of last year (Oct 15, 2003). It is an intellectual property business that commercializes modern technology rights. Ipo has a series of contracts with top universities such as Oxford, York and Southampton. It is mainly involved in scientific intellectual property (IP), such as gene research. They develop long term relationships with the Universities of 15 to 25 years.

The objective is to licence IP, or make money from the equity from the companies that they spin off. Already they have spun off HepCgen in whom they have a 24% stake. HepCgen have signed contracts with major pharmaceutical companies to provide diagnostic tests for detecting Hepatitis C in patients.

The venture capital companies have taken a serious interest in IPO, perhaps because they understand them better than most. Also Evolution Group (supposedly one of the hottest smaller co brokers around) have taken a 40 % stake in them. Right now they seem to be going into vertical lift-off mode. I suspect there will be further announcements in due course. Could be worth a dabble but, as always, dyor.

Boiiiinnnggg !!!

Said Zeberdee

(Up over 6% today)

Why is it that with this share - even when the majority of trades are a buy the price drops - could someone be milking it?

This one has been in my draw for years I bought at 75p about 4 years ago and threw them in draw, they are long termers and will show good but slow results.

How once they bust out I think there is alot to offer.

Same problem with MLR the stock is dead right on all fronts but it just can not break throught the 15p barrier.

Once its does though its flying.

IPO IP Group

Chart looks like its presenting a buying opportunity.

Fundies look good going into 2011 aswell..

IP Group Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield

31-Dec-10 12.40 5.20 2.03p 15.5 n/a n/a n/a 0.0%

31-Dec-11 18.50 10.25 4.01p 7.9 0.1 +97% n/a 0.0%

3 year chart


1 year chart

If markets are blue tomorrow hoping this one has a good day.

Print Monday 16 August, 2010IP Group PLC
Chamelic successfully complet
RNS Number : 0980R
IP Group PLC
16 August 2010



16 August 2010



IP Group plc - Portfolio company Chamelic successfully completes 1m funding round



IP Group plc (LSE: IPO) ("IP Group"), the developer of intellectual property based businesses, is pleased to announce that portfolio company Chamelic Limited ("Chamelic" or "the Company"), a spin-out company from the University of Leeds, has successfully completed a 1m fundraising.



Investors in the 1m funding round, which is tranched and contingent on certain milestones being met, included IP Group, IP Venture Fund, managed by IP Group, Syngenta Ventures, the venture capital arm of the leading agribusiness Syngenta, and members of Chamelic's management team.



Chamelic has developed a 'stay clean' surface treatment that prevents the build up of dirt and dust on a wide range of surfaces. The treatment is invisible, easy to apply and reduces the amount of cleaning required. The hydrophilic nature of the surface treatment means that any dirt or dust is rinsed away easily and prevents the formation of drying marks on the surface while also being 'anti-fogging'.



Chamelic is selling its initial product for a bespoke application that eliminates the need to replace glazing products and is proven in delivering cost savings and environmental benefits to its partner customers. The Company will use the new funds to develop and launch additional products to provide efficiency, maintenance and cosmetic benefits across agricultural applications, solar panels, vehicles, household care products and architectural applications.



Founded in 2006, Leeds-based Chamelic is a chemistry technology company spun out of research carried out by Professor Simon Biggs at the Institute ofParticle Science and Engineering (IPSE) within the University of Leeds' Faculty of Engineering. Professor Biggs has been working in the area of colloid and particle science for over 20 years and his area expertise is in surface chemistry, particularly in the area of particle-surface interactions.





For more information, please contact:

IP Group
www.ipgroupplc.com

Alan Aubrey, Chief Executive Officer
+44 (0) 20 7444 0050

Liz Vaughan-Adams, Communications
liz.vadams@ipgroupplc.com

+44 (0) 20 7444 0062 /+44 (0) 7979 853 802

Financial Dynamics

Nice big spike today :)

can any of you learned gentlemen help, i have a small holding in ipo, can any one explain to me the constant selling of 19/20 shares every 3 minutes it seems such an insignificant amount,